Early research (Phase 1)Study completedNCT01898845What this trial is testingA Phase I Study of LEE011 in Asian PatientsWho this might be right forAdvanced Solid Tumors Novartis Pharmaceuticals 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT03114527What this trial is testingPhase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)Who this might be right forSoft Tissue Sarcoma Fox Chase Cancer Center 48
Early research (Phase 1)Ended earlyNCT02703571What this trial is testingStudy of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid TumorsWho this might be right forSolid Tumors for Phase IbPancreatic Cancer for Phase IIColorectal Cancer for Phase II Novartis Pharmaceuticals 95
Testing effectiveness (Phase 2)Active Not RecruitingNCT03944434What this trial is testingFACILE: FeAsibility of First-line RiboCIclib in OLdEr Patients with Advanced Breast CancerWho this might be right forBreast Cancer Fondazione Sandro Pitigliani 116
Not applicableActive Not RecruitingNCT06148506What this trial is testingA Prospective NIS to Evaluate the Clinical Outcomes of Risarg® (Ribociclib) Combined With Endocrine Therapy or Chemotherapy in Patients With HR+HER2 - aBC in Routine Clinical Practice in the RussiaWho this might be right forHR+HER2- Advanced Breast Cancer Novartis Pharmaceuticals 376
Testing effectiveness (Phase 2)Study completedNCT02632045What this trial is testingStudy of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ HER2- Advanced Breast CancerWho this might be right forMetastatic Breast CancerBreast Carcinoma Melissa K Accordino 169
Early research (Phase 1)Study completedNCT02586675What this trial is testingTEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast CancerWho this might be right forBreast CancerBreast Cancer - FemaleBreast Cancer - Male H. Lee Moffitt Cancer Center and Research Institute 7
Early research (Phase 1)Study completedNCT02431481What this trial is testingEvaluation of Renal Function Impairment on the Pharmacokinetics of LEE011Who this might be right forNormal Renal FunctionImpaired Renal Function Novartis Pharmaceuticals 38
Early research (Phase 1)WithdrawnNCT04585724What this trial is testingStereotactic Radiosurgery With Abemaciclib, Ribociclib, or Palbociclib in Treating Patients With Hormone Receptor Positive Breast Cancer With Brain MetastasesWho this might be right forAnatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8Metastatic Breast CarcinomaMetastatic Malignant Neoplasm in the Brain+1 more Emory University
Early research (Phase 1)Study completedNCT02088684What this trial is testingStudy of LEE011 With Fulvestrant and BYL719 or BKM120 in Advanced Breast CancerWho this might be right forBreast Cancer Novartis Pharmaceuticals 70
Testing effectiveness (Phase 2)Ended earlyNCT01777776What this trial is testingSafety and Efficacy of LEE011 and LGX818 in Patients With BRAF Mutant Melanoma.Who this might be right forLocally Advanced Metastatic BRAF Mutant Melanoma Array BioPharma 28
Early research (Phase 1)Study completedNCT03237390What this trial is testingRibociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Malignant Solid NeoplasmMetastatic Malignant Solid Neoplasm Mayo Clinic 43
Testing effectiveness (Phase 2)Study completedNCT03484923What this trial is testingStudy of Efficacy and Safety of Novel Spartalizumab Combinations in Patients With Previously Treated Unresectable or Metastatic MelanomaWho this might be right forMelanoma Novartis Pharmaceuticals 196
Not applicableLooking for participantsNCT07407439What this trial is testingReal-world Studies of CDK4/6 InhibitorsWho this might be right forBreast Cancer Tianjin Medical University Cancer Institute and Hospital 245
Early research (Phase 1)Ended earlyNCT04000529What this trial is testingPhase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected MalignanciesWho this might be right forNon-small Cell Lung CarcinomaHead and Neck Squamous Cell CarcinomaEsophageal SCC+2 more Novartis Pharmaceuticals 122
Early research (Phase 1)Ended earlyNCT02414724What this trial is testingRibociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forLymphomaSolid Neoplasm Roswell Park Cancer Institute 10
Testing effectiveness (Phase 2)UnknownNCT03913234What this trial is testingPhase IB & II Study of Ribociclib With Trastuzumab Plus Letrozole in Postmenopausal HR+, HER2+ Advanced Breast Cancer PatientsWho this might be right forHER2-positive Breast CancerPostmenopausalMetastatic Breast Cancer Yonsei University 95
Testing effectiveness (Phase 2)Looking for participantsNCT05900206What this trial is testingTrastuzumab Deruxtecan Versus Standard Neoadjuvant Treatment for HER2-positive Breast CancerWho this might be right forBreast Cancer Karolinska University Hospital 370
Testing effectiveness (Phase 2)Looking for participantsNCT07164976What this trial is testingRibociclib for HR-positive HER2-negative Metastatic Breast CancerWho this might be right forBreast Cancer Nagoya City University 86
Testing effectiveness (Phase 2)Study completedNCT02300987What this trial is testingA Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent ProgressionWho this might be right forTeratoma Novartis Pharmaceuticals 10